Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment

NCT03706625 · clinicaltrials.gov ↗
COMPLETED
Status
201
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Assistance Publique - Hôpitaux de Paris